Relmada Therapeutics, Inc. Share Price
NASDAQ: RLMD | Micro CapRelmada Therapeutics, Inc. Stock Performance
Open $4.63 | Prev. Close $4.53 | Circuit Range N/A |
Day Range $4.36 - $4.63 | Year Range $0.56 - $7.99 | Volume 1,70,759 |
Average Traded $4.45 |
Relmada Therapeutics, Inc. Share Price Today
As of 12 August 2026, Relmada Therapeutics, Inc.'s share price is $4.47. The stock opened at $4.63, compared to its previous close of $4.53. During today's trading session, Relmada Therapeutics, Inc.'s share price traded between $4.36 and $4.63, with an average price of $4.49. Over the past 52 weeks, the stock has recorded a high of $7.99 and a low of $0.56. In terms of performance, Relmada Therapeutics, Inc.'s share price has declined by 1.32% over the last six months and is up 300.90% on a year-on-year basis.
Relmada Therapeutics, Inc. Share Price Chart
Relmada Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $176.47M | PE Ratio (TTM) -3.08 | Dividend Yield N/A |
EPS (TTM) $-1.45 | Revenue (TTM) N/A | Return On Equity (TTM) -66.33% |
Profit Margin N/A | Debt to Equity 0.07 | Quarterly Earnings Growth YoY 53.55% |
Relmada Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Relmada Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Relmada Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $5.09 | $4.46 | -15.91% |
Jul 2026 | $6.83 | $5.31 | -23.38% |
Jun 2026 | $7.03 | $6.93 | -4.02% |
May 2026 | $7.61 | $7.22 | -4.18% |
Apr 2026 | $7.03 | $7.54 | +8.57% |
Mar 2026 | $4.71 | $6.94 | +53.20% |
Feb 2026 | $3.68 | $4.53 | +27.61% |
Jan 2026 | $4.75 | $3.55 | -26.42% |
Dec 2025 | $4.44 | $4.83 | +6.75% |
Nov 2025 | $2.19 | $4.52 | +103.60% |
Oct 2025 | $2.13 | $2.22 | +10.17% |
Sep 2025 | $1.14 | $2.02 | +80.72% |
RLMD Share Price FAQs
What is Relmada Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Relmada Therapeutics, Inc. stock?
What is RLMD's market capitalisation today?
What is RLMD's net income for the last quarter?
What is the 5 year returns of RLMD?
What is the high & low stock price of RLMD today?
Can I buy RLMD shares in India?